Shailendra K Gautam Selected Research

Mucin-4

1/2020	MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy.
5/2019	Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shailendra K Gautam Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 01/2019
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2017
5	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2019
5	Adenocarcinoma 01/2022 - 05/2016
2	Colonic Neoplasms (Colon Cancer) 03/2020 - 05/2016
2	Colorectal Neoplasms (Colorectal Cancer) 03/2020 - 05/2016
2	Disease Progression 05/2019 - 01/2017
2	Adenoma (Adenomas) 01/2017 - 05/2016
2	Polyps 01/2017 - 05/2016
1	Breast Neoplasms (Breast Cancer) 10/2020
1	Metaplasia 01/2020
1	Pancreatitis 01/2020
1	Carcinoma in Situ 01/2020
1	Inflammation (Inflammations) 01/2020
1	Carcinoma (Carcinomatosis) 05/2016
1	Parasitic Diseases (Parasitic Disease) 01/2014

Drug/Important Bio-Agent (IBA)

5	MucinsIBA 03/2020 - 05/2016
3	AntigensIBA 01/2021 - 01/2019
3	Polysaccharides (Glycans)IBA 03/2020 - 05/2016
2	Endothelins (Endothelin)IBA 01/2022 - 01/2020
2	AntibodiesIBA 12/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2016
2	Mucin-4IBA 01/2020 - 05/2019
1	Bosentan (Tracleer)FDA Link 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	Neuropilin-2IBA 01/2022
1	Endothelin Receptor AntagonistsIBA 01/2022
1	VaccinesIBA 12/2021
1	Indicators and Reagents (Reagents)IBA 12/2021
1	cabozantinibIBA 10/2020
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	ErbB Receptors (EGF Receptor)IBA 10/2020
1	neratinibIBA 10/2020
1	Endothelin-1 (Endothelin 1)IBA 01/2020
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2020
1	Amylases FDA Link 01/2020
1	CeruletideIBA 01/2020
1	SmokeIBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 05/2019
1	Immunodominant EpitopesIBA 01/2019
1	Histocompatibility Antigens Class IIBA 01/2019
1	EpitopesIBA 05/2016
1	Peptides (Polypeptides)IBA 01/2014

Therapy/Procedure

5	Immunotherapy 01/2022 - 01/2019
5	Therapeutics 01/2022 - 01/2017
1	Radiotherapy 01/2022
1	Radioimmunotherapy 01/2019
1	Immunomodulation 01/2019